 | • レポートコード：B-GIR09F3423 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ラニビズマブの世界市場について調べ、まとめました。種類別セグメントは、使い捨てプレフィルドシリンジ、使い捨てガラスバイアル等、用途別セグメントは、wAMD、糖尿病網膜症（DR）、糖尿病黄斑浮腫（DME）、mCNV、RVO等に区分しました。ラニビズマブの世界市場概観、企業動向、企業別ラニビズマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ラニビズマブの市場概観 ・ラニビズマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ラニビズマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ラニビズマブの世界市場規模 ・ラニビズマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ラニビズマブのアメリカ市場規模推移 ・ラニビズマブのカナダ市場規模推移 ・ラニビズマブのメキシコ市場規模推移 ・ラニビズマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ラニビズマブのドイツ市場規模推移 ・ラニビズマブのイギリス市場規模推移 ・ラニビズマブのロシア市場規模推移 ・ラニビズマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ラニビズマブの日本市場規模推移 ・ラニビズマブの中国市場規模推移 ・ラニビズマブの韓国市場規模推移 ・ラニビズマブのインド市場規模推移 ・ラニビズマブの東南アジア市場規模推移 ・ラニビズマブの南米市場分析（ブラジル、アルゼンチン等） ・ラニビズマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ラニビズマブの種類別分析/販売量、売上、市場シェア（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル） ・ラニビズマブの用途別分析/市場規模（wAMD、糖尿病網膜症（DR）、糖尿病黄斑浮腫（DME）、mCNV、RVO） ・ラニビズマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ラニビズマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.
Scope of the Report:
The global Ranibizumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ranibizumab.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Ranibizumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ranibizumab market by product type and applications/end industries.
Market Segment by Companies, this report covers
Genentech
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single-use prefilled syringe
Single-use glass vial
Market Segment by Applications, can be divided into
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
Table of Contents
1 Ranibizumab Market Overview
1.1 Product Overview and Scope of Ranibizumab
1.2 Classification of Ranibizumab by Types
1.2.1 Global Ranibizumab Revenue Comparison by Types (2019-2024)
1.2.2 Global Ranibizumab Revenue Market Share by Types in 2018
1.2.3 Single-use prefilled syringe
1.2.4 Single-use glass vial
1.3 Global Ranibizumab Market by Application
1.3.1 Global Ranibizumab Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 wAMD
1.3.3 Diabetic Retinopathy (DR)
1.3.4 Diabetic Macular Edema (DME)
1.3.5 mCNV
1.3.6 RVO
1.4 Global Ranibizumab Market by Regions
1.4.1 Global Ranibizumab Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Ranibizumab Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Ranibizumab Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ranibizumab Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Ranibizumab Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ranibizumab Status and Prospect (2014-2024)
1.5 Global Market Size of Ranibizumab (2014-2024)
2 Manufacturers Profiles
2.1 Genentech
2.1.1 Business Overview
2.1.2 Ranibizumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Genentech Ranibizumab Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Ranibizumab Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ranibizumab Market Competition, by Players
3.1 Global Ranibizumab Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Ranibizumab Players Market Share
3.2.2 Top 10 Ranibizumab Players Market Share
3.3 Market Competition Trend
4 Global Ranibizumab Market Size by Regions
4.1 Global Ranibizumab Revenue and Market Share by Regions
4.2 North America Ranibizumab Revenue and Growth Rate (2014-2019)
4.3 Europe Ranibizumab Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Ranibizumab Revenue and Growth Rate (2014-2019)
4.5 South America Ranibizumab Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Ranibizumab Revenue and Growth Rate (2014-2019)
5 North America Ranibizumab Revenue by Countries
5.1 North America Ranibizumab Revenue by Countries (2014-2019)
5.2 USA Ranibizumab Revenue and Growth Rate (2014-2019)
5.3 Canada Ranibizumab Revenue and Growth Rate (2014-2019)
5.4 Mexico Ranibizumab Revenue and Growth Rate (2014-2019)
6 Europe Ranibizumab Revenue by Countries
6.1 Europe Ranibizumab Revenue by Countries (2014-2019)
6.2 Germany Ranibizumab Revenue and Growth Rate (2014-2019)
6.3 UK Ranibizumab Revenue and Growth Rate (2014-2019)
6.4 France Ranibizumab Revenue and Growth Rate (2014-2019)
6.5 Russia Ranibizumab Revenue and Growth Rate (2014-2019)
6.6 Italy Ranibizumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Ranibizumab Revenue by Countries
7.1 Asia-Pacific Ranibizumab Revenue by Countries (2014-2019)
7.2 China Ranibizumab Revenue and Growth Rate (2014-2019)
7.3 Japan Ranibizumab Revenue and Growth Rate (2014-2019)
7.4 Korea Ranibizumab Revenue and Growth Rate (2014-2019)
7.5 India Ranibizumab Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Ranibizumab Revenue and Growth Rate (2014-2019)
8 South America Ranibizumab Revenue by Countries
8.1 South America Ranibizumab Revenue by Countries (2014-2019)
8.2 Brazil Ranibizumab Revenue and Growth Rate (2014-2019)
8.3 Argentina Ranibizumab Revenue and Growth Rate (2014-2019)
8.4 Colombia Ranibizumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Ranibizumab by Countries
9.1 Middle East and Africa Ranibizumab Revenue by Countries (2014-2019)
9.2 Saudi Arabia Ranibizumab Revenue and Growth Rate (2014-2019)
9.3 UAE Ranibizumab Revenue and Growth Rate (2014-2019)
9.4 Egypt Ranibizumab Revenue and Growth Rate (2014-2019)
9.5 Nigeria Ranibizumab Revenue and Growth Rate (2014-2019)
9.6 South Africa Ranibizumab Revenue and Growth Rate (2014-2019)
10 Global Ranibizumab Market Segment by Type
10.1 Global Ranibizumab Revenue and Market Share by Type (2014-2019)
10.2 Global Ranibizumab Market Forecast by Type (2019-2024)
10.3 Single-use prefilled syringe Revenue Growth Rate (2014-2024)
10.4 Single-use glass vial Revenue Growth Rate (2014-2024)
11 Global Ranibizumab Market Segment by Application
11.1 Global Ranibizumab Revenue Market Share by Application (2014-2019)
11.2 Ranibizumab Market Forecast by Application (2019-2024)
11.3 wAMD Revenue Growth (2014-2019)
11.4 Diabetic Retinopathy (DR) Revenue Growth (2014-2019)
11.5 Diabetic Macular Edema (DME) Revenue Growth (2014-2019)
11.6 mCNV Revenue Growth (2014-2019)
11.7 RVO Revenue Growth (2014-2019)
12 Global Ranibizumab Market Size Forecast (2019-2024)
12.1 Global Ranibizumab Market Size Forecast (2019-2024)
12.2 Global Ranibizumab Market Forecast by Regions (2019-2024)
12.3 North America Ranibizumab Revenue Market Forecast (2019-2024)
12.4 Europe Ranibizumab Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Ranibizumab Revenue Market Forecast (2019-2024)
12.6 South America Ranibizumab Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Ranibizumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Ranibizumab Picture
Table Product Specifications of Ranibizumab
Table Global Ranibizumab and Revenue (Million USD) Market Split by Product Type
Figure Global Ranibizumab Revenue Market Share by Types in 2018
Figure Single-use prefilled syringe Picture
Figure Single-use glass vial Picture
Table Global Ranibizumab Revenue (Million USD) by Application (2014-2024)
Figure Ranibizumab Revenue Market Share by Applications in 2018
Figure wAMD Picture
Figure Diabetic Retinopathy (DR) Picture
Figure Diabetic Macular Edema (DME) Picture
Figure mCNV Picture
Figure RVO Picture
Table Global Market Ranibizumab Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Ranibizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Ranibizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Ranibizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Ranibizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Ranibizumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Ranibizumab Revenue (Million USD) and Growth Rate (2014-2024)
Table Genentech Basic Information, Manufacturing Base and Competitors
Table Genentech Ranibizumab Type and Applications
Table Genentech Ranibizumab Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Ranibizumab Type and Applications
Table Novartis Ranibizumab Revenue, Gross Margin and Market Share (2017-2018)
Table Global Ranibizumab Revenue (Million USD) by Players (2014-2019)
Table Global Ranibizumab Revenue Share by Players (2014-2019)
Figure Global Ranibizumab Revenue Share by Players in 2017
Figure Global Ranibizumab Revenue Share by Players in 2018
Figure Global Top 5 Players Ranibizumab Revenue Market Share in 2018
Figure Global Top 10 Players Ranibizumab Revenue Market Share in 2018
Figure Global Ranibizumab Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Ranibizumab Revenue (Million USD) by Regions (2014-2019)
Table Global Ranibizumab Revenue Market Share by Regions (2014-2019)
Figure Global Ranibizumab Revenue Market Share by Regions (2014-2019)
Figure Global Ranibizumab Revenue Market Share by Regions in 2018
Figure North America Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Europe Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Ranibizumab Revenue and Growth Rate (2014-2019)
Figure South America Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Ranibizumab Revenue and Growth Rate (2014-2019)
Table North America Ranibizumab Revenue by Countries (2014-2019)
Table North America Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure North America Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure North America Ranibizumab Revenue Market Share by Countries in 2018
Figure USA Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Canada Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Mexico Ranibizumab Revenue and Growth Rate (2014-2019)
Table Europe Ranibizumab Revenue (Million USD) by Countries (2014-2019)
Figure Europe Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure Europe Ranibizumab Revenue Market Share by Countries in 2018
Figure Germany Ranibizumab Revenue and Growth Rate (2014-2019)
Figure UK Ranibizumab Revenue and Growth Rate (2014-2019)
Figure France Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Russia Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Italy Ranibizumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Ranibizumab Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Ranibizumab Revenue Market Share by Countries in 2018
Figure China Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Japan Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Korea Ranibizumab Revenue and Growth Rate (2014-2019)
Figure India Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Ranibizumab Revenue and Growth Rate (2014-2019)
Table South America Ranibizumab Revenue by Countries (2014-2019)
Table South America Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure South America Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure South America Ranibizumab Revenue Market Share by Countries in 2018
Figure Brazil Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Argentina Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Colombia Ranibizumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Ranibizumab Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ranibizumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Ranibizumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Ranibizumab Revenue and Growth Rate (2014-2019)
Figure UAE Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Egypt Ranibizumab Revenue and Growth Rate (2014-2019)
Figure Nigeria Ranibizumab Revenue and Growth Rate (2014-2019)
Figure South Africa Ranibizumab Revenue and Growth Rate (2014-2019)
Table Global Ranibizumab Revenue (Million USD) by Type (2014-2019)
Table Global Ranibizumab Revenue Share by Type (2014-2019)
Figure Global Ranibizumab Revenue Share by Type (2014-2019)
Figure Global Ranibizumab Revenue Share by Type in 2019
Table Global Ranibizumab Revenue Forecast by Type (2019-2024)
Figure Global Ranibizumab Market Share Forecast by Type (2019-2024)
Figure Global Single-use prefilled syringe Revenue Growth Rate (2014-2019)
Figure Global Single-use glass vial Revenue Growth Rate (2014-2019)
Table Global Ranibizumab Revenue by Application (2014-2019)
Table Global Ranibizumab Revenue Share by Application (2014-2019)
Figure Global Ranibizumab Revenue Share by Application (2014-2019)
Figure Global Ranibizumab Revenue Share by Application in 2019
Table Global Ranibizumab Revenue Forecast by Application (2019-2024)
Figure Global Ranibizumab Market Share Forecast by Application (2019-2024)
Figure Global wAMD Revenue Growth Rate (2014-2019)
Figure Global Diabetic Retinopathy (DR) Revenue Growth Rate (2014-2019)
Figure Global Diabetic Macular Edema (DME) Revenue Growth Rate (2014-2019)
Figure Global mCNV Revenue Growth Rate (2014-2019)
Figure Global RVO Revenue Growth Rate (2014-2019)
Figure Global Ranibizumab Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Ranibizumab Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Ranibizumab Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Ranibizumab Revenue Market Forecast (2019-2024)
Figure Europe Ranibizumab Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Ranibizumab Revenue Market Forecast (2019-2024)
Figure South America Ranibizumab Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Ranibizumab Revenue Market Forecast (2019-2024)
世界のセルトリズマブペゴル市場予測（～2024年） Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Scope of the Report: The global Certolizumab pegol market is valued at xx million USD in 2018 and is expected to reach xx…- 世界のドリペネム市場予測（～2024年）：企業別、地域別、種類・用途別 Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudo…
- 世界の一塩基多型（SNP）ジェノタイピングおよび分析市場予測（～2024年）：企業別、地域別、種類・用途別 SNP genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. Scope of the Report: The global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis market is valued at xx million USD in 2018 and is expected to reach xx million …
- 世界のミルセラ（メトキシポリエチレングリコールエポエチンベータ）市場予測（～2024年）：企業別、地域別、種類・用途別 Mircera (methoxy polyethylene glycol-epoetin beta) is used to treat patients with symptomatic anaemia associated with chronic kidney disease (CKD). Scope of the Report: The global Mircera (methoxy polyethylene glycol-epoetin beta) market is valued at xx million USD in 2018 and is expected to reach x…
- 世界のシングルモード光ファイバーケーブルアセンブリ市場予測（～2024年） Fiber optic cable assemblies consist of an optical fiber, a reinforcement strand for support, and fiber optic connectors. Fiber Optic Cable is a cable containing one or more optical fibers that are used to carry light. The optical fiber elements are typically individually coated with plastic layers …